Global Longlife Hospital and Research Limited
ListedSMEHealthcare · BSE
Global Longlife Hospital and Research Limited is an NABH-accredited multi-speciality tertiary care hospital based in Ahmedabad, Gujarat, offering a wide range of healthcare services including oncology, ophthalmology, cardiology, dermatology, gynecology, spine and plastic surgery, dialysis, physiotherapy, ultrasound, and microbiology. The hospital has a capacity of 110 well-equipped beds supporting both medical and surgical specialties, and as of December 31, 2021, it is supported by 11 full-time consultants, over 30 experienced consulting doctors, 37 nurses, and more than 50 paramedical, pharmacy, corporate, and support staff, ensuring comprehensive and quality patient care.
Price Band
₹140
Issue Size
₹49.00 Cr
Lot Size
1000 shares
GMP
₹1
+0.7%
Est. Listing
₹141
at current GMP
Subscribed
—
Open
21 Apr 2022
Close
25 Apr 2022
Allotment
30 Apr 2022
Refund
1 May 2022
Demat Credit
2 May 2022
Listing
4 May 2022
Last updated 12 days ago
Key Highlights
- •Leading player in the Healthcare segment
- •Price band established at ₹140 - ₹140 per equity share
- •Minimum bid lot is 1000 shares
- •Estimated listing target of ₹141 based on current grey market activity